Chris Burns
CEO of Amplia Therapeutics, a Melbourne, Australia, based biotech developing a pipeline of small molecule FAK inhibitors for cancer and fibrotic diseases. Our lead asset is narmafotinib currently in a Phase 2a trial in pancreatic cancer (NCT05355298).
@uoe-igc.bsky.social
Our mission is to improve the lives of people living with genetic disease and cancer through research.
@dcshuang.bsky.social
Biomedical researcher at WEHI. BCL2, mitochondria, apoptosis and targeted therapies for leukemias/lymphomas.
@rscmedchem.rsc.org
The journal for research and review articles in medicinal chemistry and related drug discovery science. Published by @rsc.org 🌐 Website: rsc.li/rscmedchem
@drewberry.bsky.social
Biomedical animation at WEHI, Melbourne Australia Animation playlist https://www.youtube.com/playlist?list=PLD0444BD542B4D7D9
@wehi-research.bsky.social
🔬 We research and develop treatments for cancer, diseases of development and ageing, immune disorders and infections. https://www.wehi.edu.au
@cancerparisnord.bsky.social
L’Institut du #Cancer AP-HP. Nord - Université Paris Cité acteur majeur de la cancérologie en Ile-de-France. 🔬🦠 https://institutducancer-hopitauxnord-u-paris.aphp.fr/
@katesears.bsky.social
Hi I'm Kate, community lead for Medical.watch. Want practice changing updates in oncology/hematology? Get our weekly newsletter and join 2400+ clinicians. Subscribe for free: Medical.watch About us: tinyurl.com/Medicalwatch
@garvaninstitute.bsky.social
@mveg001.bsky.social
Executive, NED | Strategy, Leadership, Advocacy | Industry-Academia-Gov | Director, Australia’s Cell & Gene Catalyst, AusBiotech & Medicines Australia | Ambassador, Women in STEMM | Consultant, Career Coach | She/her | #AusCatalyst #Wurundjeri #Australia
@targetovarian.bsky.social
We’re targeting what’s important – symptoms awareness, life-saving early diagnosis, better treatments and support for everyone affected by ovarian cancer. targetovariancancer.org.uk
@nci-psrc.bsky.social
We are a NCI funded consortium that is focused on understanding how to reprogram the stroma in pancreatic ductal adenocarcinoma (PDAC) in order to improve treatment responses and enhance survival. The coordinating center for PSRC is based at MD Anderson.
@letswinpc.org
Let’s Win is your guide to hope and action. Our mission is to guide pancreatic cancer patients with vital information for better outcomes. 💜 https://letswinpc.org #PancChat #PancSM #PancSky
@mpm-lab.bsky.social
@pancan.bsky.social
Our vision is to create a world in which all patients with pancreatic cancer will thrive. 💜 pancan.org
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: [email protected]